S. Massucco

Triple-M syndrome after immune checkpoint inhibitors: a systematic review of cases-early recognition is critical to survival.

Introduction Immune checkpoint inhibitors have markedly improved outcomes in advanced malignancies by enhancing antitumor immunity, but they may also disrupt immune tolerance and induce immune-related adverse events involving multiple organs; among these, the overlap of myositis, myocarditis, and Myasthenia Gravis (tri...